Skip To The Main Content

Conference Puts Human Face on Cell and Gene Therapies

cell gene therapy

Cell and gene therapies will unquestionably comprise a large part of biotech companies’ portfolios in the coming decades. Unlike traditional large molecules, these products have different manufacturing and supply chain needs, requiring a fresh look at existing regulations. Yet these challenges will need to be addressed due to the promise of these products to cure a variety of diseases and disorders.